| Application | Recommended Dilution |
|---|---|
| IHC | 1:50-1:200 |
Aquaporin-4 represents the predominant water channel in the central nervous system, playing essential roles in brain water homeostasis, astrocyte function, and cerebrospinal fluid dynamics. Beyond its neurological significance, AQP4 has emerged as a molecule of considerable interest in cancer research, where its expression patterns may influence tumor cell migration and edema formation. The protein also participates in metabolic processes and signal transduction pathways, making it a valuable target for researchers investigating diverse physiological and pathological mechanisms.
This recombinant monoclonal antibody, clone 22F10, offers the reproducibility and consistency that demanding research protocols require. Generated through recombinant technology with a defined sequence, this antibody eliminates the lot-to-lot variability that can compromise longitudinal studies or multi-site collaborations. The rabbit host origin and monoclonal nature ensure high specificity for human AQP4, with the antibody raised against a synthetic peptide immunogen derived from the human protein sequence.
Validation in immunohistochemistry demonstrates reliable performance in paraffin-embedded human tissue sections. Testing in human lung cancer tissue using a Leica Bond system with citrate buffer antigen retrieval and HRP-polymer detection produced clear staining at 1:50 dilution, with a recommended working range of 1:50 to 1:200 allowing optimization for different tissue types and detection systems. The antibody is also validated for ELISA applications, providing flexibility across experimental platforms.
Supplied in a stabilized liquid format with glycerol for convenient long-term storage, this antibody serves researchers exploring AQP4 biology in oncology, metabolic regulation, and cellular signaling contexts where consistent, sequence-defined reagents are essential for generating reliable data.
Email: support@cusabio.com
Distributors Worldwide